PubMed Health⌕ Search

PubMed · 13880442

Cell wall replication in Streptococcus pyogenes.

Abstract

Group A streptococci (Streptococcus pyogenes) of several different serological types were grown in fluorescein-labeled homologous type or group-specific globulins, thereby labeling the antigen-containing cell walls. Specific precipitation or inhibition of the labeled antibody, followed by continued incubation and examination at intervals by ultraviolet, phase, and dark-field microscopy, showed that new cell wall was then nonfluorescent. These nonfluorescent portions were differentiated by a reverse technique of culture in unlabeled globulin, followed by antibody precipitation, further growth, and fluorescent-antibody staining. This technique of differential labeling of cell wall has permitted following, for the first time in a living system, the fate of cell wall formed at different times. The results suggest that cell wall synthesis in actively growing cultures usually occurs simultaneously at at least two sites per coccus, each site representing stages in successive divisions, and that cell wall growth in Streptococcus pyogenes is not by diffuse intercalation with old wall, but is initiated at and extends both peripherally and centripetally from the coccal equator.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R M COLE, J J HAHN. 1962-03-02. Cell wall replication in Streptococcus pyogenes.. https://doi.org/10.1126/science.135.3505.722

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

An ordinary differential equation model for the multistep transformation to cancer.

Cancer is viewed as a multistep process whereby a normal cell is transformed into a cancer cell through the acquisition of mutations. We reduce the complexities of cancer progression to a simple set of underlying rules that govern the transformation of normal cells to malignant cells. In doing so, we derive an ordinary differential equation model that explores how the balance of angiogenesis, cell death rates, genetic instability, and replication rates give rise to different kinetics in the development of cancer. The key predictions of the model are that cancer develops fastest through a particular ordering of mutations and that mutations in genes that maintain genomic integrity would be the most deleterious type of mutations to inherit. In addition, we perform a sensitivity analysis on the parameters included in the model to determine the probable contribution of each. This paper presents a novel approach to viewing the genetic basis of cancer from a systems biology perspective and provides the groundwork for other models that can be directly tied to clinical and molecular data.

Cell Division↗

Neuromedin B and its receptor are mitogens in both normal and malignant epithelial cells lining the colon.

Bombesin-like peptides are uniformly thought to act as mitogens in cancer. Yet by studying human tissues, we have recently shown that bombesin and its mammalian homologue gastrin-releasing peptide act as morphogens, promoting tumor differentiation when aberrantly upregulated in colon cancer. In contrast, little is known about the bombesin-like peptide neuromedin B (NMB) and its receptor (NMB-R) in the human gastrointestinal tract. We therefore studied their presence and function in normal and malignant human colonic epithelia. Anti-NMB monoclonal antibodies were made against keyhole limpet hemocyanin (KLH)-conjugated human NMB, whereas anti-NMB-R antibodies were raised in rabbits against KLH-conjugated peptides corresponding to the third intracellular loop and COOH-terminal tail of the receptor protein. NMB antibody recognized two bands at approximately 1.2 kDa and approximately 1.5 kDa. NMB-R antibodies recognized a band at 80 kDa (predicted 43 kDa); whereas treatment with the deglycosylating agent peptide-N-glycosidase generated bands at 65, 47, and 43 kDa. By immunohistochemistry, both NMB and NMB-R were expressed in normal and cancerous colonic epithelial tissues. In cancer, the amount of NMB was similar to that expressed by proliferating epithelial cells located within the crypt. In contrast, NMB-R expression was increased in cancer, with higher levels detected in better differentiated tumor cells. To assess NMB function, proliferation was determined in the nonmalignant human colonic epithelial cell line NCM-460 and in the colon cancer cell lines Caco-2 and HT-29. Exogenously added NMB was 50-100% more efficacious than gastrin-releasing peptide in causing tumor cell proliferation, whereas only NMB increased NCM-460 cell proliferation. These findings indicate that NMB and its receptor are coexpressed by proliferating cells in which they act in an autocrine fashion with similar and modest potency in both normal and malignant colonic epithelial cells.

Cell Division↗